


Healthcare News Roundup: Oncology
HSMN NewsFeed - 27 Jul 2020
AxoProtego Therapeutics Announces Novel Investigational Agent for Chemotherapy-Induced Peripheral Neuropathy
AxoProtego Therapeutics Announces Novel Investigational Agent for Chemotherapy-Induced Peripheral Neuropathy
HSMN NewsFeed - 23 Jul 2020
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
HSMN NewsFeed - 15 Jul 2020
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
HSMN NewsFeed - 8 Jul 2020
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
HSMN NewsFeed - 7 Jul 2020
HiberCell Announces Acquisition of Biothera Pharmaceuticals' Imprime PGG Program
HiberCell Announces Acquisition of Biothera Pharmaceuticals' Imprime PGG Program
HSMN NewsFeed - 23 Jun 2020
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
HSMN NewsFeed - 16 Jun 2020
EXUMA Biotech Adds H. Michael Shepard to Scientific Advisory Board and Steven R. Frank to Board of Directors
EXUMA Biotech Adds H. Michael Shepard to Scientific Advisory Board and Steven R. Frank to Board of Directors
HSMN NewsFeed - 15 Jun 2020
Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat(R) Research
Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat(R) Research
HSMN NewsFeed - 11 Jun 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
